Autism Spectrum Disorder Trial, Recruiting NCT05815095 Sponsor: Centre Hospitalier Intercommunal Creteil Condition: Autism Spectrum Disorder
Back to Autism Spectrum Disorder

Autism Spectrum Disorder Trial, Recruiting

NCT05815095
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • The trial is open to infants between 4 and 9 months old who are being seen at participating Maternal and Child Protection Services for their required 4-month or 9-month vaccinations
  • At least one parent must have access to a personal telephone
  • Parents must be willing to provide consent for their child to take part and agree to active follow-up of the child until 36 months of age
  • The child must be covered by a social security system or by state medical assistance
  • Either a parent or a close relative who speaks French must be present, or the parent must have a basic understanding of French, as determined by the principal investigator

Who may not be able to join:

  • Infants who have a serious neurological condition, such as encephalopathy (a brain disorder), would not be eligible
  • Families who do not wish to take part in the study would not be eligible

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 01 47 06 49 25

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Centre Hospitalier Intercommunal Creteil
Registry
ClinicalTrials.gov
Start date
14 April 2025
Est. completion
14 April 2030

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Proportion of children at 24 months with an Autism Spectrum Disorder or Neurodevelopmental Disorder diagnosis who received care before the age of one

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov